Previous 10 | Next 10 |
Gainers: Seneca Biopharma (SNCA) +25%, DarioHealth (DRIO) +25%, Dyadic International DYAI +24%, Marker Therapeutics (MRKR) +19%, Immunocore Holdings (IMCR) +11%.Losers: Odonate Therapeutics ODT -76%, Foghorn Therapeutics (FHTX) -13%,...
Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...
Biotech Penny Stocks Catching Attention From Robinhood Traders Should you buy penny stocks this week? It has become one of the hottest trends in the stock market today. These low-priced stocks continue creating a buzz among retail traders of all backgrounds. If 2020 taught us one thing,...
Are These Robinhood Penny Stocks On Your Buy Or Sell List Right Now? As we end another week in March, both penny stocks and blue chips remain highly volatile. Overall this month has been quite bullish for many stocks under $5, yet broader markets continue trading sideways. Several facto...
Gainers: Clovis Oncology (CLVS) +61%.ZK International (ZKIN) +47%.SuperCom (SPCB) +47%.SenesTech (SNES) +45%.AudioEye (AEYE) +29%.Super League Gaming (SLGG) +27%.Marker Therapeutics (MRKR) +26%.Hall of Fame Resort & Entertainment (HOFV) +25%.X4 Pharmaceuticals (XFOR) +...
Gainers: Clovis Oncology (CLVS) +43%, Marker Therapeutics (MRKR) +23%, Alector (ALEC) +17%, Aravive (ARAV) +14%, Ortho Clinical Diagnostics (OCDX) +8%.Losers: Idera Pharmaceuticals (IDRA) -62%, Praxis Precision Medicines (PRAX) -13%, Acu...
Marker Therapeutics (MRKR) is trading 27.8% higher premarket after the company disclosed in regulatory filings that CEO Peter L. Hoang bought $250K worth of shares, Chief Development Officer Juan Vera bought ~$1M of shares and board members John Robert Wilson and Steven El...
SenesTech (SNES) +83% on successful completion of a long term agricultural deployment of ContraPest®ZK International Group (ZKIN) +31%.Marker Therapeutics (MRKR) +28% as as Cantor initiates with high target and insider buying.Clovis Oncology (CLVS) +20% as ARIEL4 study met...
Marker Therapeutics (MRKR) is trading 38.9% higher premarket after the company disclosed in regulatory filings that CEO Peter L. Hoang bought $250K of shares, Chief development officer Juan Vera bought ~$1M of shares and Board members John Robert Wilson and Steven Elm...
Gainers: [[AAME]] +31.5%. [[MRKR]] +28.3%. [[KNSA]] +13.8%. [[WKEY]] +11.8%. [[SRPT]] +7.6%.Losers: [[PROG]] -6%. [[UPST]] -5.8%. [[ALPN]] -5.8%. [[SYBX]] -4.7%. [[ROAD]] -4.4%. For further details see: SRPT, UPST, MRKR and ALPN among after-hours movers
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary safety and efficacy with sustained objective responses observed in patients with lymphoma treated with MT-601 in Phase 1 APOLLO study Study participant with Non-Hodgkin’s Lymphoma who relapsed within 90 days of anti-CD19 CAR T cell therapy remains in complete response...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...